SSII
SS Innovations International, Inc.
$3.94
-1.38%
$800.5M
No data for this timeframe.
Vol
Market Cap$800.5M
Cap SizeSmall Cap
Inst. Holders2 funds
Inst. Value$18.5K
Inst. Activity2 buys / 0 sells
Insider Activity3B / 0S
Insider Net $$5.2M
SEC Reports8
Press Releases1
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. FL·CIK 0001676163·Prev Close $4.00
Recent Activity
May 20, 2026
SEC
SS Innovations filed a 424B5 prospectus to register up to $150M in securities for future sale by the company and 5,016,5
424B5 — Impact 6/10
May 20, 2026
earnings_calendar
SSII Q1 2026 Earnings Scheduled — 2026-05-20
May 13, 2026
SEC
SS Innovations reported record Q1 2026 revenue of $11.1M, up 116.8% YoY, driven by strong SSi Mantra system installation
8-K — Impact 6/10
May 12, 2026
Insider
Sudhir Srivastava sold 21,506 shares
Chairman and CEO @ $5.00 ($107.5K)
May 7, 2026
SEC
SS Innovations announced a successful long-distance cross-border telesurgery demonstration using its SSi Mantra robotic
8-K — Impact 3/10
Apr 14, 2026
Insider
Sudhir Srivastava sold 10,000 shares
Chairman and CEO @ $0.00 ($0.00)
Apr 6, 2026
Insider
Cohen Barry F sold 19,000 shares
COO - Americas @ $5.58 ($106.0K)
Inst.
UBS Group AG — NEW
51,189 shares ($301.5K)
Latest Reports
BEARISH
424B5
6/10
SS Innovations filed a 424B5 prospectus to register up to $150M in securities for future sale by the company and 5,016,5
May 20, 2026
MIXED
8-K
6/10
SS Innovations reported record Q1 2026 revenue of $11.1M, up 116.8% YoY, driven by strong SSi Mantra system installation
May 13, 2026
BULLISH
Press
8/10
SS Innovations reported strong full-year 2025 revenue growth of 105.7% to $42.5 million with expanding gross margins and
Mar 10, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $17.0K | NEW |
| WELLS FARGO & COMPANY/MN | $1.5K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 12, 2026 | Sudhir Srivastava | J | $107.5K |
| Apr 14, 2026 | Sudhir Srivastava | G | $0.00 |
| Apr 6, 2026 | Cohen Barry | J | $106.0K |
| Apr 1, 2026 | Cohen Barry | G | $0.00 |
| Mar 30, 2026 | Sudhir Srivastava | G | $0.00 |
2 institutional holders with $18.5K total value (3,260 shares) as of 2025-Q4. Top holders: MORGAN, WELLS.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 3,000 | $17.0K | 92.0% | NEW |
| 2 | WELLS FARGO & COMPANY/MN | 260 | $1.5K | 8.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | NEW | — | 51,189 | — | $301.5K | 2025-Q2 |
| MORGAN STANLEY | NEW | — | 3,000 | — | $17.7K | 2025-Q2 |
5 unique insiders with 3 transactions. Net insider value: $5.2M ($5.2M bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 12, 2026 | Sudhir Srivastava | Chairman and CEO | J | 21,506 | $5.00 | $107.5K |
| Apr 14, 2026 | Sudhir Srivastava | Chairman and CEO | G | 10,000 | $0.00 | $0.00 |
| Apr 6, 2026 | Cohen Barry F | COO - Americas | J | 19,000 | $5.58 | $106.0K |
| Apr 1, 2026 | Cohen Barry F | COO - Americas | G | 7,000 | $0.00 | $0.00 |
| Mar 30, 2026 | Sudhir Srivastava | Chairman and CEO | G | 246,000 | $0.00 | $0.00 |
| Mar 25, 2026 | Sudhir Srivastava | Chairman and CEO | G | 10,000 | $0.00 | $0.00 |
| Mar 6, 2026 | MOLL FREDERIC H | Director | BUY | 501,253 | $3.99 | $2.0M |
| Mar 6, 2026 | Adams Timothy P. | Director | BUY | 300,000 | $3.99 | $1.2M |
| Mar 6, 2026 | Sudhir Srivastava | Chairman and CEO | BUY | 498,753 | $4.01 | $2.0M |
| Mar 2, 2026 | Cohen Barry F | COO - Americas | J | 32,000 | $6.63 | $212.2K |
| Feb 20, 2026 | Vishwajyoti Pascual Srivastava | CEO - Asia Pacific | G | 2,000,000 | $0.00 | $0.00 |
| Feb 20, 2026 | Sudhir Srivastava | Chairman and CEO | G | 2,000,000 | $0.00 | $0.00 |
8 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 1 mixed, 5 neutral. Avg impact: 4.1/10.
BEARISH
424B5
6/10
SS Innovations filed a 424B5 prospectus to register up to $150M in securities for future sale by the
May 20, 2026
MIXED
8-K
6/10
SS Innovations reported record Q1 2026 revenue of $11.1M, up 116.8% YoY, driven by strong SSi Mantra
May 13, 2026
NEUTRAL
8-K
3/10
SS Innovations announced a successful long-distance cross-border telesurgery demonstration using its
May 7, 2026
NEUTRAL
8-K
3/10
SS Innovations announced via press release that its SSi Mantra surgical robotic system has surpassed
May 5, 2026
NEUTRAL
8-K
3/10
SS Innovations unveiled several conceptual surgical robotic technologies at its hosted conference, i
Apr 23, 2026
NEUTRAL
8-K
3/10
SS Innovations International, Inc. announced it is hosting the Global Multi-Specialty Robotic Surger
Apr 7, 2026
NEUTRAL
10-K/A
2/10
SS Innovations International filed an amended 10-K/A solely to include Exhibit 97.1, its Clawback Po
Mar 31, 2026
BULLISH
8-K
7/10
SS Innovations announced regulatory approval for its SSi Mantra surgical robotic system to perform t
Mar 18, 2026
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 20, 2026
earnings_calendar
SSII Q1 2026 Earnings Scheduled — 2026-05-20
May 13, 2026
earnings
SS Innovations Reports First Quarter 2026 Financial Results
SS Innovations Reports First Quarter 2026 Financial Results
May 13, 2026
earnings_calendar
SSII Q1 2026 Earnings Scheduled — 2026-05-13
May 5, 2026
other
SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System
SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System
Apr 13, 2026
earnings_calendar
SSII Q4 2025 Earnings Scheduled — 2026-04-13
Apr 7, 2026
other
SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026
SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026
Mar 30, 2026
other
SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya
SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya
Mar 18, 2026
other
SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines
SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines
Mar 10, 2026
earnings
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 9, 2026
offering
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives